Labor priming research hub

A randomized, three-period, single-dose crossover trial in healthy female volunteers to demonstrate bioequivalence of tafoxiparin following subcutaneous administration via syringe/needle in the abdomen, and via an auto-injector in the abdomen and thigh, respectively.

This study is testing a new way to give a medicine called tafoxiparin to healthy women. It's looking at how well the medicine is absorbed when given by a needle and syringe, or by an auto-injector in two different body areas.